Prelude Therapeutics (PRLD) Capital Expenditures (2019 - 2025)
Prelude Therapeutics (PRLD) recorded Capital Expenditures of $67,000 in FY2025, down 91.2% from $764,000 in FY2024.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Capital Expenditures (2019 - 2025) Analysis & Trends
Starting with FY2019, Prelude Therapeutics' Capital Expenditures history includes 7 years.
- Annual Capital Expenditures has a five-year compound annual growth rate of -35.9% (FY2020 to FY2025).
- The FY2025 figure is the lowest annual Capital Expenditures in data going back to FY2019.
- Per Business Quant data, PRLD's Capital Expenditures was $764,000 in FY2024 (-78.3%), $3.51 million in FY2023 (+16.4%), $3.02 million in FY2022 (+30.0%) and $2.32 million in FY2021 (+274.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Prelude Therapeutics | 312.03 Mn | -285.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 53,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 359,000.00 |
| Mar 31, 2024 | 289,000.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 591,000.00 |
| Jun 30, 2023 | 983,000.00 |
| Mar 31, 2023 | 810,000.00 |
| Dec 31, 2022 | 393,000.00 |
| Sep 30, 2022 | 916,000.00 |
| Jun 30, 2022 | 758,000.00 |
| Mar 31, 2022 | 952,000.00 |
| Dec 31, 2021 | 297,000.00 |
| Sep 30, 2021 | 659,000.00 |
| Jun 30, 2021 | 381,000.00 |
| Mar 31, 2021 | 986,000.00 |
| Dec 31, 2020 | 329,000.00 |
| Sep 30, 2020 | 170,000.00 |
API Access
Prelude Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();